Authors:
BENJAPIBAL M
KUDELKA AP
VASURATNA A
EDWARDS CL
VERSCHRAEGEN CF
VALERO V
VADHANRAJ S
KAVANAGH JJ
Citation: M. Benjapibal et al., DOCETAXEL AND CYCLOPHOSPHAMIDE-INDUCED REMISSION IN PLATINUM AND PACLITAXEL REFRACTORY OVARIAN-CANCER, Anti-cancer drugs, 9(6), 1998, pp. 577-579
Authors:
DIAZCANTON EA
VALERO V
RAHMAN Z
RODRIGUEZMONGE E
FRYE D
SMITH T
BUZDAR AU
HORTOBAGYI GN
Citation: Ea. Diazcanton et al., CLINICAL COURSE OF BREAST-CANCER PATIENTS WITH METASTASES CONFINED TOTHE LUNGS TREATED WITH CHEMOTHERAPY, Annals of oncology, 9(4), 1998, pp. 413-418
Authors:
VALERO V
AZARNIA N
BUZDAR A
THERIAULST R
WILLEY J
LEE L
HORTOBAGYI G
Citation: V. Valero et al., A PHASE-II STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN), IN COMBINATION WITH (5-FU) AND CYCLOPHOSPHAMIDE (CPA) IN THE TREATMENT OFMETASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 65-65
Authors:
VALERO V
BURRIS H
JONES S
EARHART R
VONHOFF D
HORTOBAGYI G
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 66-66
Authors:
VALERO V
HOFF P
SINGLETARY ES
BUZDAR AU
BOOSER DJ
ASMAR L
MCNEESE M
HORTOBAGYI GN
Citation: V. Valero et al., TAMOXIFEN AS PRIMARY THERAPY IN COMBINED-MODALITY TREATMENT OF ELDERLY PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 78-78
Authors:
VALERO V
BUZDAR AU
ASMAR L
THERIAULT RL
BOOSER DJ
MCNEESE M
SINGLETARY SE
HORTOBAGYI GN
Citation: V. Valero et al., ADJUVANT ANTHRACYCLINE-CONTAINING THERAPY IN WOMEN GREATER-THAN-OR-EQUAL-TO-65 YEARS WITH BREAST-CANCER - THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE, Annals of oncology, 9, 1998, pp. 144-144
Authors:
VALERO V
HOLMES FA
FRYE D
THERIAULT RL
ESPARZAGUERRA L
HORTOBAGYI GN
Citation: V. Valero et al., PACLITAXEL AS A SINGLE-AGENT THERAPY IN WOMEN GREATER-THAN-OR-EQUAL-TO-65 YEARS WITH PREVIOUSLY TREATED METASTATIC BREAST-CANCER - THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE, Annals of oncology, 9, 1998, pp. 145-145
Authors:
VALERO V
JONES SE
VONHOFF DD
BOOSER DJ
MENNEL RG
RAVDIN PM
HOLMES FA
RAHMAN Z
SCHOTTSTAEDT MW
ERBAN JK
ESPARZAGUERRA L
EARHART RH
HORTOBAGYI GN
BURRIS HA
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3362-3368
Authors:
BRUNO R
HILLE D
RIVA A
VIVIER N
HUINNINK WWTB
VANOOSTEROM AT
KAYE SB
VERWEIJ J
FOSSELLA FV
VALERO V
RIGAS JR
SEIDMAN AD
CHEVALLIER B
FUMOLEAU P
BURRIS HA
RAVCLIN PM
SHEINER LB
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/, Journal of clinical oncology, 16(1), 1998, pp. 187-196
Authors:
PUSZTAI L
WALTERS RS
VALERO V
THERIAULT RL
HORTOBAGYI GN
Citation: L. Pusztai et al., DAILY ORAL ETOPOSIDE IN PATIENTS WITH HEAVILY PRETREATED METASTATIC BREAST-CANCER, American journal of clinical oncology, 21(5), 1998, pp. 442-446
Authors:
WALTERS RS
HOLMES FA
VALERO V
ESPARZAGUERRA L
HORTOBAGYI GN
Citation: Rs. Walters et al., PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN PATIENTS WITH METASTATIC BREAST-CANCER, American journal of clinical oncology, 21(4), 1998, pp. 413-415
Authors:
HOFF PM
VALERO V
IBRAHIM N
WILLEY J
HORTOBAGYI GN
Citation: Pm. Hoff et al., HAND-FOOT SYNDROME FOLLOWING PROLONGED INFUSION OF HIGH-DOSES OF VINORELBINE - AUTHOR REPLY, Cancer, 83(5), 1998, pp. 1054-1055
Authors:
RAHMAN Z
CHAMPLIN R
RONDON G
FRYE D
VALERO V
MEHRA R
HORTOBAGYI G
Citation: Z. Rahman et al., PHASE I II STUDY OF DOSE-INTENSE DOXORUBICIN/PACLITAXEL/CYCLOPHOSPHAMIDE WITH PERIPHERAL-BLOOD PROGENITOR CELLS AND CYTOKINE SUPPORT IN PATIENTS WITH METASTATIC BREAST-CANCER/, Seminars in oncology, 24(5), 1997, pp. 77-80
Citation: Jpm. Ayoub et al., TAMOXIFEN-INDUCED FEMALE ANDROGENETIC ALOPECIA IN A PATIENT WITH BREAST-CANCER, Annals of internal medicine, 126(9), 1997, pp. 745-746
Authors:
HOLMES FA
MADDEN T
NEWMAN RA
VALERO V
THERIAULT RL
FRASCHINI G
WALTERS RS
BOOSER DJ
BUZDAR AU
WILLEY J
HORTOBAGYI GN
Citation: Fa. Holmes et al., SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2713-2721
Authors:
DUVIC M
LEMAK NA
VALERO V
HYMES SR
FARMER KL
HORTOBAGYI GN
TRANCIK RJ
BANDSTRA BA
COMPTON LD
Citation: M. Duvic et al., A RANDOMIZED TRIAL OF MINOXIDIL IN CHEMOTHERAPY-INDUCED ALOPECIA, Journal of the American Academy of Dermatology, 35(1), 1996, pp. 74-78
Authors:
CERVANTES M
ZHOU HY
SAHIN A
DHINGRA K
VALERO V
ORDONEZ N
ELNAGGAR A
HESS K
GLASSMAN A
SEN S
Citation: M. Cervantes et al., P53 ALTERATIONS SHOW SIGNIFICANT CORRELATION WITH GENE AMPLIFICATION AND S-PHASE INDEX IN BREAST-CANCER, International journal of oncology, 6(5), 1995, pp. 955-962
Authors:
VALERO V
BOOSER D
THERIAULT R
ESPARZA L
GAGNON S
HORTOBAGYI G
Citation: V. Valero et al., PILOT-STUDY OF TAXOTERE IN TAXOL-RESISTANCE METASTATIC BREAST-CANCER (TRMBC), European journal of cancer, 31A, 1995, pp. 384-384